A carregar...
Identification of enzymes involved in oxidation of phenylbutyrate
In recent years the short-chain fatty acid, 4-phenylbutyrate (PB), has emerged as a promising drug for various clinical conditions. In fact, PB has been Food and Drug Administration-approved for urea cycle disorders since 1996. PB is more potent and less toxic than its metabolite, phenylacetate (PA)...
Na minha lista:
| Publicado no: | J Lipid Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The American Society for Biochemistry and Molecular Biology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5408614/ https://ncbi.nlm.nih.gov/pubmed/28283530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M075317 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|